Renegade.bio

Renegade.bio is a private, Berkeley-based public benefit corporation focused on improving access to diagnostic testing, particularly for infectious diseases and sexual health. The company emerged during the COVID-19 pandemic with rapid PCR-based testing and process innovations intended to simplify and speed testing workflows. It later expanded into at-home and community-based screening offerings, including PrEP/STI testing under the Renegade.Health brand. Renegade.bio also appears to support diagnostic development and deployment with biotech and community partners through in-house laboratory and operational capabilities. Overall, the company is best characterized as a diagnostics and health-access company rather than a therapeutics developer.